Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.39 |
| ▸ | RECQL | P46063 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | XBP1 | P17861 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11533969 | 1.00 | MAPT (0.39) | MAPTRECQLTDP1XBP1NPSR1 | |
| SCHEMBL11537134 | 1.00 | MAPT (0.39) | MAPTRECQLTDP1XBP1NPSR1 | |
| SCHEMBL8944922 | 0.82 | CA14 (0.43) | MAPTRECQLALDH1A1MEN1KMT2A | |
| SCHEMBL6446520 | 0.81 | PSENEN (0.41) | TDP1NPSR1ALDH1A1CA14CTSK | |
| SCHEMBL2555385 | 0.81 | MAPT (0.39) | MAPTRECQLTDP1XBP1NPSR1 | |
| SCHEMBL30170109 | 0.79 | CA14 (0.36) | TDP1NPSR1CA14CTSKPOLB | |
| SCHEMBL21488593 | 0.78 | CA2 (0.34) | ALDH1A1POLBCA2 | |
| SCHEMBL24796325 | 0.78 | CA12 (0.40) | MAPTRECQLTDP1XBP1NPSR1 | |
| SCHEMBL23607312 | 0.78 | CA1 (0.52) | MAPTNPSR1KMT2ACA14CTSK | |
| SCHEMBL23849248 | 0.78 | CA1 (0.52) | MAPTNPSR1KMT2ACA14CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12404299-B2 | Method for producing peptide compound comprising highly sterically hindered amino acid | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-02 | — | — | US | disclosed |
| EP-4056580-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND COMPRISING HIGHLY STERICALLY HINDERED AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-09-14 | — | — | EP | disclosed |
| US-4140496-A | GAS CHROMATOGRAPHY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1979-02-20 | — | — | US | disclosed |
| US-4104040-A | Use of s-triazine derivatives in a gas chromatographic method | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1978-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12404299-B2 | Method for producing peptide compound comprising highly sterically hindered amino acid | DNPEP, VIP, NPEPPS | MAPT 2810/4885RECQL 4867/4885TDP1 4557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.